The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

BSX FINANCIAL STATEMENTS

Boston Scientific Corp — balance sheet, income statement and cash flow trends

BSXBoston Scientific Corp

🇺🇸 USA · US · Healthcare · Medical Devices

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
010 B20 B202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue21 B $Gross Profit14.9 B $ · 71%Operating Income4.5 B $ · 21%Pre-tax Income3.9 B $ · 18%Net Income to Owners3.7 B $ · 17%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue21 B $+13.5%
Gross Profit14.9 B $+27.8%
Operating Income4.5 B $+51.3%
EBITDA5.5 B $+17.0%
Net Income to Owners3.7 B $+46.5%

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
020 B40 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets45.2 B
  • Equity24.9 B $55%
  • Current Liabilities6.4 B $14%
  • Long-term Liabilities13.6 B $30%

Key Figures

YoY change
Total Assets45.2 B $+8.8%
Total Liabilities20 B $+6.0%
Total Equity24.9 B $+11.2%
Cash & ST Investments539 M $+0.9%
Total Debt12.6 B $+5.0%
Net Debt12.1 B $+5.2%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
02 B4 B202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
02 B4 B4.5 B $Operating-3.6 B $Investing-958 M $Financing10 M $Net Change

Key Figures

YoY change
Operating Cash Flow4.5 B $+5.7%
Capital Expenditures904 M $-7.2%
Free Cash Flow3.6 B $+9.5%
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on BSX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.